Northwest Medical Isotopes

Northwest Medical Isotopes, LLC, based in Corvallis, Oregon, specializes in the production and distribution of molybdenum-99 (Mo-99), a crucial radioisotope used in medical imaging for diagnosing conditions such as cancer, heart disease, and bone and kidney diseases. Founded in 2010, the company addresses the ongoing Mo-99 supply crisis by employing low-energy, cost-effective, and sustainable manufacturing processes. It focuses on designing, licensing, constructing, and operating facilities that facilitate the fabrication, recovery, and purification of Mo-99 from irradiated low-enriched uranium (LEU) targets. By enabling the domestic production of this essential medical isotope, Northwest Medical Isotopes aims to enhance the availability of diagnostic and therapeutic imaging technologies for healthcare providers across the United States. The company operates as a subsidiary of Samaritan Health Services, Inc.